Tenon Medical completed financing transactions to support growth and liquidity, entering securities purchase agreements with investors and a placement agency agreement with WallachBeth Capital. The best efforts public offering raised $4.2 million in gross proceeds at a combined price of $0.38 per share or pre-funded warrant, alongside common warrants equal to 120% of shares purchased and exercisable at $0.38 for five years. Proceeds will fund partial repayment of convertible notes, commercial expansion, clinical and R&D programs, inventory, and general corporate purposes. The agreements include a 30-day issuance standstill, a three-month variable rate restriction, and 60-day insider lock-ups, with ATM activity permitted after 30 days.
Agreement 1: Tenon Medical Raises $4.2 Million in Equity Offering; Issues Warrants at $0.38
- Agreement type: Securities purchase agreements for best efforts public offering of equity and warrants
- Counterparty: Investors
- Signed / Effective: Jun 29 2026 / Jul 01 2026
- Duration / Termination: N/A
- Reason: Raise capital for operations and debt repayment
Agreement 2: Tenon Medical Engages WallachBeth Capital as Placement Agent for Equity Offering
- Agreement type: Placement agency agreement for public offering
- Counterparty: WallachBeth Capital
- Signed / Effective: Jun 29 2026 / Jun 29 2026
- Duration / Termination: N/A
- Reason: Engage agent to place securities in offering
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.